David D. Stenehjem
- Oncology top 5%
- Internal Medicine top 1%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Cardiology and Cardiovascular Medicine top 5%
- Co-authors
- Jeffrey A. GilreathGeorge M. RodgersMarcello Di NisioGary H. LymanCihan AyAndrew D. LeavittWojtek WierciochLisa K. Hicks
- Topics
- Cancer Genomics and Diagnostics (20 papers)Cancer Immunotherapy and Biomarkers (20 papers)Lung Cancer Treatments and Mutations (16 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United StatesAustriaCanada
In The Last Decade
David D. Stenehjem
102 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Oncology 626
- Internal Medicine 438
- Pulmonary and Respiratory Medicine 402
- Molecular Biology 318
- Cardiology and Cardiovascular Medicine 318
Countries citing papers authored by David D. Stenehjem
This map shows the geographic impact of David D. Stenehjem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David D. Stenehjem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David D. Stenehjem more than expected).
Fields of papers citing papers by David D. Stenehjem
This network shows the impact of papers produced by David D. Stenehjem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David D. Stenehjem. The network helps show where David D. Stenehjem may publish in the future.
Co-authorship network of co-authors of David D. Stenehjem
This figure shows the co-authorship network connecting the top 25 collaborators of David D. Stenehjem. A scholar is included among the top collaborators of David D. Stenehjem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David D. Stenehjem. David D. Stenehjem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 6 | |
| 6 | 2 | |
| 7 | 14 | |
| 8 | American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancerbreakdown → | 489 |
| 9 | 88 | |
| 10 | 8 | |
| 11 | 21 | |
| 12 | 16 | |
| 13 | 67 | |
| 14 | 5 | |
| 15 | 2 | |
| 16 | 11 | |
| 17 | 17 | |
| 18 | 34 | |
| 19 | 102 | |
| 20 | 11 |
About David D. Stenehjem
David D. Stenehjem is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 113 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (20 papers), Cancer Immunotherapy and Biomarkers (20 papers) and Lung Cancer Treatments and Mutations (16 papers). The work is most often cited by research in Internal Medicine (438 citations), Oncology (626 citations) and Emergency Medical Services (145 citations). David D. Stenehjem has collaborated with scholars based in United States, Austria and Canada. Frequent co-authors include Jeffrey A. Gilreath, George M. Rodgers, Marcello Di Nisio, Gary H. Lyman, Cihan Ay, Andrew D. Leavitt, Wojtek Wiercioch, Lisa K. Hicks, Rebecca L. Morgan and Fergus Macbeth. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.